AU2008229609B2 — Pleuromutilin derivatives for the treatment of diseases mediated by microbes
Assigned to Nabriva Therapeutics AG · Expires 2012-03-29 · 14y expired
What this patent protects
A compound of formula (I) wherein n is 0 to 4; m is 0 or 1 with the proviso that the sulphur atom and R are in vicinal position (if m = 0 then R is in position 2', and if m = 1 then R is on position 1'); R is ethyl or vinyl; R is hydrogen or (C)alkyl; R is hydrogen or - (C)cycloa…
USPTO Abstract
A compound of formula (I) wherein n is 0 to 4; m is 0 or 1 with the proviso that the sulphur atom and R are in vicinal position (if m = 0 then R is in position 2', and if m = 1 then R is on position 1'); R is ethyl or vinyl; R is hydrogen or (C)alkyl; R is hydrogen or - (C)cycloalkyl, or - unsubstituted (C)alkyl, or - (C)alkyl substituted by one or more of - hydroxy; preferably one or two, - methoxy, - halogen, - (C)cycloalkyl, or Rand R together with the nitrogen atom to which they are attached form a 5 to 7 membered heterocyclic ring containing at least 1 nitrogen atom or 1 nitrogen and 1 additional heteroatome e. g. selected from N or O, or R is hydroxy and R is formyl; R is OH, OR, a halogen atom, or - with the proviso that R is bound to 2' R represents -O-(CH)-O- with p is 2 or 3; R is unsubstituted (C)alkyl or (C)cycloalkyl.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.